Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

Admelog is Sanofi’s version of Humalog (insulin lispro). New prescription savings card is for both Admelog and Lantus for people who would otherwise need to pay full...
When the benefits seem “long term,” it’s easy to deprioritize habits today. How to overcome the time perspective challenge – and it costs nothing!
Healthcare professionals are increasingly recognizing peer support as a valuable element of diabetes care; read for a list of peer support communities
Less intimidating insertion for pump users: peel tape, remove cover, one button to insert; available in Europe, with more countries coming later this year
A positive 8-0 vote at the FDA paves the way for first implanted CGM to come to the US; read what patient advocates and healthcare providers like about Eversense!
New dose adjustment recommendations for adults and children using Dexcom's G5 CGM based on trend arrows and insulin sensitivity
Physicians, diabetes educators, and research scientists share their own health bright spots in food and exercise, technology, and more
If you have a Fitbit, check out the diabetes communities in the app for tips and support from fellow people with diabetes
Dexcom G6 cleared by FDA with no fingerstick calibrations, 10-day wear time, approval for ages 2 years and older, no acetaminophen interference, and more
As early as 2019, the FDA could approve SGLT-2 inhibitors for adults with type 1, but some patients are already using these pills “off label”; see guidance from leading...
Toujeo Max SoloStar will launch later this year in the US. It holds 900 units of insulin and can dose up to 160 units in one injection, meaning fewer refills and...
Ultra-slim patch supports convenient mealtime insulin dosing; wearers just hit two buttons simultaneously to deliver 2 units at a time; acquired by CeQur as J&J...
A unique mindset to resist tempting foods, including in peer-pressured group settings
Experts and innovators from all corners gathered to share the latest in new technology and treatments for people with diabetes, focusing on improving CGM and outcomes...
ADA is around the corner, and there’s going to be exciting updates on diabetes drugs and therapy, devices, big picture questions, #beyondA1C, and advocacy; stay tuned!
Limited launch in May-July. No receiver! Smartphone-only display on Apple iOS devices. Plus, the new “personal diabetes assistant,” Sugar.IQ with Watson
Learn more about DiabetesMine D-Data highlights, implantable CGM Eversense used in adolescents, and Sugar.IQ real-world data
Low-cost education services can help you learn new skills to eat well, stay active, and monitor blood sugar levels
Recruiting now! This major study will support FDA submission of Tandem’s t:slim X2 with Control-IQ and Dexcom G6 in people with type 1 ages 14 and up; includes automatic...
FDA clearance and limited US launch expected in the second half of 2018. Dash adds improved user experience, Bluetooth, smartphone viewing, remote monitoring

Pages